This compound is a steroidal pharmaceutical intermediate characterized by a tetracyclic ring system and multiple chiral centers. Its primary significance lies in its use as a building block for the synthesis of specialized steroid derivatives.
نطاق المحتوى: تتعلق المعلومات الواردة في هذه الصفحة بتحديد المواد الكيميائية وبسياقات التوريد الصناعي والبحث والإنتاج. وهي لا تشكّل ادعاءً علاجياً أو نصيحة طبية أو إرشادات لاستخدام الأدوية.
هل تشتري أو تورد هذا المركب؟
أضف مخزونك أو أنشر طلب شراء
CAS 459789-97-0
(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
active pharmaceutical ingredient
(R)-4-((3R,5S,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
active pharmaceutical ingredient
6,7-DIHYDROXY-3,4-DIHYDROISOQUINOLINE
pharmaceutical intermediate
(1R,2R)-(-)-1,2-CYCLOHEXANEDICARBOXYLIC ACID
Pharmaceutical intermediate for lurasidone
3-hydroxy-2,3-dimethylbutan-2-yl hydrogen (10-phenylanthracen-9-yl)boronate
synthetic intermediate for boron-containing compounds
1,1,1-Trifluoro-4-iodobutane
Pharmaceutical intermediate
3alpha-Hydroxy-7-oxo-5beta-cholan-24-oic acid methyl ester
bile acid intermediate for drug synthesis
7-Ketolithocholic acid
bile acid intermediate
ethyl (4R)-4-[(3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
PRZCLWHVOYRZJL-GAKWKJAJSA-N
CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3C1=O)CC[C@@H]4[C@H](C)CCC(=O)OCC)C)C)O
—